Replies to post #2726 on Ayala Pharmaceuticals Inc (ADXS)

[csf_dialysis]

Barney

The squamous cell carcinoma needs to be removed surgically. Depending on the extent of metastasis, perhaps arming the Listeria with the "Rhenium-188, a radionuclide that kills cells by releasing DNA-damaging radiation and has shown promising results in a handful of early stage trials against a variety of cancers. Sure enough, regular injections of Rhenium-188-labeled L. monocytogenes decreased metastases by 90 percent over saline-injected mice."

If this option was available, then I would consider it along with the SURGERY. ADXS is really losing out..and you guys will certainly be picking up the tab here.

[csf_dialysis]

Sorry, not a buyer above 1.83 from many technical issues I have raised. Neither should you be, IMO. Best of Luck! I did own ADXS in 2009 about 896000 shares at 2-3 cents, and later sold it 18-22 cents. ADXS is very OVERVALUED now pricewise compared to other developmental bio-techs.